22 results
8-K
EX-10.1
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
or sold in a single package or container, or otherwise co-prescribed or bundled as a single unit, and sold for a single price. [***]
“Commercial
DEFA14A
ELYM
Eliem Therapeutics Inc
11 Apr 24
Additional proxy soliciting materials
8:10am
with each of the third party vendors that manufacture, process, package, or supply ingredients and packaging materials for or distribute the Company
8-K
EX-2.1
ELYM
Eliem Therapeutics Inc
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
, as required, and the Company has established and maintains a quality agreement with each of the third party vendors that manufacture, process, package
DEFA14A
409zl1 hb
6 Apr 23
Additional proxy soliciting materials
4:10pm
DEFA14A
1enk0tf
8 Apr 22
Additional proxy soliciting materials
4:25pm
10-K
k4kbpaypueeeg
7 Mar 22
Annual report
4:03pm
424B4
39g30gt82s2anvfigbg7
11 Aug 21
Prospectus supplement with pricing info
5:05pm
S-1/A
4cap6r1
2 Aug 21
IPO registration (amended)
6:08am
S-1/A
EX-1.1
94k wbdc07
2 Aug 21
IPO registration (amended)
6:08am
S-1/A
EX-10.5
fgeueuoknk uhic
2 Aug 21
IPO registration (amended)
6:08am
S-1/A
EX-10.6
j7k0j0cm
2 Aug 21
IPO registration (amended)
6:08am
S-1
z92zpgypc
16 Jul 21
IPO registration
5:02pm
DRS/A
bnjl6jhpi0woxr5onun6
12 Jul 21
Draft registration statement (amended)
12:00am